Trial Profile
Double blind placebo-controlled study on the efficacy of melatonin on sleep, resulting in an improved quality of life in hemodialysis patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2022
Price :
$35
*
At a glance
- Drugs Melatonin (Primary)
- Indications Sleep disorders
- Focus Biomarker; Therapeutic Use
- Acronyms MELODY
- 15 Jul 2011 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 15 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Feb 2010 Planned end date changed from 1 Jun 2009 to 1 Apr 2010 as reported by ClinicalTrials.gov.